Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations

Relative benefits of bioresorbable vascular scaffolds (BVS) compared with everolimus-eluting stents (EES) are expected to accrue after complete bioresorption.



Titolo: Decision Analytic Markov Model Weighting Expected Benefits and Current Limitations of First-Generation Bioresorbable Vascular Scaffolds: Implications for Manufacturers and Next Device Iterations
Autori interni: 
CAPODANNO, DAVIDE FRANCESCO MARIA (Corresponding)
BUCCHERI, SERGIO
CAPRANZANO, PIERA
TAMBURINO, Corrado
mostra contributor esterni 
Data di pubblicazione: 2018
Rivista: 
CIRCULATION. CARDIOVASCULAR INTERVENTIONS.  
Abstract: Relative benefits of bioresorbable vascular scaffolds (BVS) compared with everolimus-eluting stents (EES) are expected to accrue after complete bioresorption.
Handle: http://hdl.handle.net/20.500.11769/315228
Appare nelle tipologie:1.1 Articolo in rivista

File in questo prodotto:
Non ci sono file associati a questo prodotto.
Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/20.500.11769/315228
  • Citazioni
  • PubMed Central
  • Scopus
  • WOS

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2020